Release Date: 18/03/14 10:13 Summary: MTE: On Market Take-over Bid Price Sensitive: Yes Download Document 99.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%